Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
adalimumab (humira) (1 trial)
bt-11 (5 trials)
nx-13 (3 trials)
labp-104 (1 trial)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Crohn Disease (Phase 2)
Ulcer (Phase 2)
Trials (9 total)
Trial APIs (4 total)